ChiCTR1900021581
尚未开始
/
/
/
2019-02-28
/
/
Study on malignant tumour
微生物群與癌症治療
癌症治療後口腔和腸道微生物群變化的觀察性研究
000
Primary objective: 1. Delineate changes in gut and oral microbial community profiles of cancer therapy patients before and after therapy. Secondary objectives: 2. Correlate baseline gut and oral microbial community profiles with the origin of primary tumours; 3. Correlate changes in gut and oral microbial community profiles with the development of toxicity; 4. Compare gut and oral microbial community profiles between cancer patients and age-/sex-matched healthy controls (to be recruited under another study with ethics approval obtained).
析因分组（即根据危险因素或暴露因素分组）
Ⅰ期
N/A
Open
香港中文大學
/
100;50;150
/
2019-03-05
2021-03-04
/
1. Chinese people aged 18 or above, no upper age limit; 3. Having newly diagnosed malignant tumour; 4. A new case referred to the Oncology Centre for management.；
登录查看1. Patients who have previously received cancer therapy; 2. Patients who will receive concurrent radiotherapy; 3. Patients with conditions rendering them incapable to answer questionnaires or provide oral and stool samples; 4. Subjects who are unable to give consent.；
登录查看香港中文大學微生物學系
000
昌郁医药2024-11-22
上海和誉生物医药科技有限公司2024-11-22
云顶新耀2024-11-22
金斯瑞生物2024-11-22
细胞与基因治疗领域2024-11-22
肝脏时间2024-11-22
医药笔记2024-11-22
生物安全情报网2024-11-22
医药速览2024-11-22
亚盛医药2024-11-22
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
